Effect of deflazacort on pregnancy outcome in kidney transplant patients: should we change the immunosuppressant before conception?

Table 4 Unadjusted odds ratios of factors in clinical pregnancy

Factors	Unadjusted OR (95% CI)	P value
Age (years)	0.87 (0.72–1.06)	0.17
Duration tried to conceive (months)	0.98 (0.96–1.0)	0.09
Years since transplantation (years)	0.94 (0.80–1.10)	0.45
Hypertension	1.48 (0.37–5.96)	0.58
Serum BUN (mg/dL)	0.94 (0.87–1.03)	0.19
eGFR	1.03 (0.99–1.07)	0.09
Graft rejection	0.12 (0.02–0.65)	0.01
Diabetes mellitus	0.16 (0.004–7.09)	0.35
Cause of ESRD
Unknown	1
SLE	0.07 (0.002–2.49)	0.15
Glomerulonephritis	0.93 (0.16–5.38)	0.94
Ig A nephropathy	1.36 (0.2–9.56)	0.75
Congenital anomaly	0.13 (0.002–6.82)	0.31
Diabetes melitus	0.16 (0.001–25.91)	0.48
Use of ART	0.36 (0.1–1.33)	0.13
CyA	2.1 (0.55–8.0)	0.28
TAC	0.62 (0.17–2.25)	0.46
DFZ	0.09 (0.02–0.53)	0.007
Pred	2.23 (0.63–7.93)	0.21
Aza	0.29 (0.05–1.75)	0.18
MMF	0.88 (0.19–4.16)	0.88

Note: ART assisted reproductive techniques, SBP systolic blood pressure, DBP diastolic blood pressure, BUN blood urea nitrogen, eGFR estimated glomerular filtration rate, ESRD end stage renal disease, SLE systemic lupus erythematous, Ig immunoglobulin, CyA cyclosporine, TAC tacrolimus, DFZ deflazacort, Pred predinosolone, Aza azathioprine, MMF mycophenolate mofetil, OR odds ratio, CI confidence interval

ISSN: 1471-2369